株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腎透析装置:医療機器のパイプライン評価

Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 350915
出版日 ページ情報 英文 235 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
腎透析装置:医療機器のパイプライン評価 Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2017
出版日: 2017年10月11日 ページ情報: 英文 235 Pages
概要

当レポートでは、世界の腎臓透析装置の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 腎臓透析装置市場の概要

第3章 腎臓透析装置市場:治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 腎臓透析装置の企業:治験段階別のパイプライン製品
  • 腎臓透析装置:治験段階別のパイプライン製品

第5章 腎臓透析装置市場:企業・製品の概要

  • 3S BioMedical, Inc.
    • パイプライン製品および進行中の治験の概要
  • Advanced Dialysis Methods Ltd.
  • AngioDynamics, Inc.
  • ARISTE Medical
  • 旭化成
  • Ash Access Technology, Inc.
  • AWAK Technologies Pte Ltd
  • Baxter International Inc.
  • Blood Purification Technologies, Inc.
  • CatheNect Medical
  • Chemica Technologies, Inc.
  • Chrysalis Medical Weight Loss Clinic
  • Circuport, Inc.
  • Control Medical Technology, LLC
  • CreatiVasc Medical LLC
  • Cytograft Tissue Engineering, Inc.
  • CytoPherx, Inc.
  • Debiotech S.A.
  • DEKA Research and Development
  • Dipylon Medical AB
  • ExThera Medical LLC.
  • Fistulink Ltd.
  • Flow Forward Medical, LLC
  • Fresenius Medical Care AG & Co. KGaA
  • Fresenius Medical Care Holdings, Inc.
  • Georgia Institute of Technology
  • Glomeria Therapeutics Srl
  • Healionics Corporation
  • Laminate Medical Technologies Ltd.
  • Marvao Medical Devices Limited
  • Medtronic plc
  • Miromatrix Medical Inc.
  • Nanodialysis BV
  • NanoVasc, Inc.
  • Nicast Ltd.
  • NuVascular Technologies Inc
  • NxStage Medical, Inc.
  • PeriTec Biosciences, Ltd.
  • Phase One Medical, LLC
  • qSTAR Medical SAS
  • Quanta Fluid Solutions Ltd.
  • RenalGuard Solutions, Inc.
  • Senexis Limited (Inactive)
  • Surgical Specialties Corporation (Inactive)
  • TEI Biosciences, Inc.
  • Tengion, Inc. (Inactive)
  • University of California, San Francisco
  • University of Limerick
  • Vanderbilt University
  • Veryan Medical Limited
  • Vital Access, Corp.
  • Vivonics, Inc.
  • Vizio Medical Devices

第6章 腎臓透析装置市場:昨今の動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0465EPD

GlobalData's Medical Devices sector report, "Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2017" provides an overview of Renal Dialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Renal Dialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Renal Dialysis Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Renal Dialysis Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 12

2 Introduction 13

  • 2.1 Renal Dialysis Equipment Overview 13

3 Products under Development 15

  • 3.1 Renal Dialysis Equipment - Pipeline Products by Stage of Development 15
  • 3.2 Renal Dialysis Equipment - Pipeline Products by Segment 16
  • 3.3 Renal Dialysis Equipment - Pipeline Products by Territory 17
  • 3.4 Renal Dialysis Equipment - Pipeline Products by Regulatory Path 18
  • 3.5 Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 19
  • 3.6 Renal Dialysis Equipment - Ongoing Clinical Trials 20

4 Renal Dialysis Equipment - Pipeline Products under Development by Companies 21

  • 4.1 Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development 21
  • 4.2 Renal Dialysis Equipment - Pipeline Products by Stage of Development 23

5 Renal Dialysis Equipment Companies and Product Overview 25

  • 5.1 3S BioMedical, Inc. Company Overview 25
    • 5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.2 Advanced Dialysis Methods Ltd. Company Overview 26
    • 5.2.1 Advanced Dialysis Methods Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.3 Angiotech Pharmaceuticals Inc Company Overview 27
    • 5.3.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.4 Ariste Medical LLC Company Overview 29
    • 5.4.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.5 Asahi Kasei Corp Company Overview 30
    • 5.5.1 Asahi Kasei Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Ash Access Technology Inc Company Overview 31
    • 5.6.1 Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.7 Avenu Medical, Inc. Company Overview 33
    • 5.7.1 Avenu Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.8 AWAK Technologies Pte Ltd Company Overview 34
    • 5.8.1 AWAK Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.9 Baxter BioScience Inc Company Overview 35
    • 5.9.1 Baxter BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.10 Baxter International Inc Company Overview 36
    • 5.10.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.11 Blood Purification Technologies, Inc. Company Overview 44
    • 5.11.1 Blood Purification Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.12 Brookhaven Medical Inc Company Overview 45
    • 5.12.1 Brookhaven Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.13 CatheNect Medical Company Overview 46
    • 5.13.1 CatheNect Medical Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.14 Chemica Technologies Inc Company Overview 47
    • 5.14.1 Chemica Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.15 Chrysalis Medical Weight Loss Clinic (Inactive) Company Overview 48
    • 5.15.1 Chrysalis Medical Weight Loss Clinic (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.16 Cytograft Tissue Engineering Inc (Inactive) Company Overview 49
    • 5.16.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.17 CytoPherx, Inc. Company Overview 50
    • 5.17.1 CytoPherx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.18 Debiotech SA Company Overview 53
    • 5.18.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.19 Dipylon Medical AB Company Overview 56
    • 5.19.1 Dipylon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.20 ExThera Medical Corporation Company Overview 57
    • 5.20.1 ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.21 Fistulink Ltd. Company Overview 58
    • 5.21.1 Fistulink Ltd. Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.22 Flow Forward Medical, LLC Company Overview 59
    • 5.22.1 Flow Forward Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.23 Fresenius Kidney Care Company Overview 60
    • 5.23.1 Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.24 Fresenius Medical Care AG & Co KGaA Company Overview 61
    • 5.24.1 Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.25 Georgia Institute of Technology Company Overview 64
    • 5.25.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.26 Glomeria Therapeutics srl Company Overview 66
    • 5.26.1 Glomeria Therapeutics srl Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.27 Healionics Corporation Company Overview 68
    • 5.27.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.28 Indian Institute of Technology Bombay Company Overview 69
    • 5.28.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.29 Laminate Medical Technologies Ltd. Company Overview 70
    • 5.29.1 Laminate Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.30 LiberDi Ltd Company Overview 73
    • 5.30.1 LiberDi Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.31 Marvao Medical Devices Ltd Company Overview 74
    • 5.31.1 Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.32 Medtronic plc Company Overview 77
    • 5.32.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.33 Nanodialysis BV Company Overview 78
    • 5.33.1 Nanodialysis BV Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.34 NanoVasc, Inc. Company Overview 79
    • 5.34.1 NanoVasc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.35 Nicast Ltd Company Overview 80
    • 5.35.1 Nicast Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.36 Nikkiso Co., Ltd. Company Overview 81
    • 5.36.1 Nikkiso Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.37 NuVascular Technologies Inc Company Overview 83
    • 5.37.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.38 NxStage Medical Inc Company Overview 85
    • 5.38.1 NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.39 Peripal AG Company Overview 87
    • 5.39.1 Peripal AG Pipeline Products & Ongoing Clinical Trials Overview 87
  • 5.40 Phase One Medical LLC Company Overview 88
    • 5.40.1 Phase One Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.41 qSTAR Medical SAS Company Overview 90
    • 5.41.1 qSTAR Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 90
  • 5.42 Quanta Dialysis Technologies Ltd Company Overview 91
    • 5.42.1 Quanta Dialysis Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.43 Rambam Health Care Campus Company Overview 92
    • 5.43.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.44 Senexis Limited (Inactive) Company Overview 93
    • 5.44.1 Senexis Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.45 Simergent LLC Company Overview 94
    • 5.45.1 Simergent LLC Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.46 Tengion Inc Company Overview 96
    • 5.46.1 Tengion Inc Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.47 University of California San Francisco Company Overview 97
    • 5.47.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.48 University of Rostock Company Overview 99
    • 5.48.1 University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 99
  • 5.49 Vanderbilt University Company Overview 100
    • 5.49.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 100
  • 5.50 Vital Access Corp Company Overview 101
    • 5.50.1 Vital Access Corp Pipeline Products & Ongoing Clinical Trials Overview 101
  • 5.51 Vivonics, Inc. Company Overview 102
    • 5.51.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
  • 5.52 Vizio Medical Devices Company Overview 103
    • 5.52.1 Vizio Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 103

6 Renal Dialysis Equipment- Recent Developments 104

  • 6.1 Sep 07, 2017: Rockwell Medical Appoints John G. Cooper to Board of Directors 104
  • 6.2 Aug 28, 2017: NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage System One 104
  • 6.3 Aug 24, 2017: NxStage System One Now in Nine of Top Ten U.S. Nephrology Hospitals 105
  • 6.4 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 106
  • 6.5 Aug 21, 2017: B. Braun Launches New Dialyzer 109
  • 6.6 Aug 11, 2017: NxStage Kidney Care and Dialyze Direct to Provide On-Site Dialysis to Skilled Nursing Facility Patients in Ohio 109
  • 6.7 Aug 09, 2017: Rockwell Medical Reports Second Quarter Results 110
  • 6.8 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 110
  • 6.9 Aug 08, 2017: Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits 111
  • 6.10 Aug 07, 2017: NxStage Reports Second Quarter Financial Results 112
  • 6.11 Aug 04, 2017: Over One Hundred NxStage Patients Celebrate Ten-Year Anniversary on Home Hemodialysis with the System One 113
  • 6.12 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 114
  • 6.13 Aug 01, 2017: Laminate Medical Technologies Receives IDE Approval from FDA to Initiate Clinical Study of the VasQ Device 115
  • 6.14 Aug 01, 2017: Fresenius Medical Care delivers another quarter of strong revenue growth 116
  • 6.15 Aug 01, 2017: Fresenius confirms its guidance after a strong second quarter with double-digit sales and earnings growth 118
  • 6.16 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 121
  • 6.17 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 121
  • 6.18 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 122
  • 6.19 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 124
  • 6.20 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 126
  • 6.21 Jul 21, 2017: Fresenius appoints Rachel Empey as Chief Financial Officer 127
  • 6.22 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 127
  • 6.23 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 129
  • 6.24 Jul 13, 2017: Kimal prepares for further expansion 130
  • 6.25 Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 130
  • 6.26 Jul 10, 2017: DARPA Funds ExThera Medical's 'Seraph' Blood Filter for Pre-Clinical Testing 130
  • 6.27 Jul 10, 2017: RenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer- 131
  • 6.28 Jul 10, 2017: Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance 132
  • 6.29 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 133
  • 6.30 Jun 15, 2017: RenalGuard Solutions Appoints J. Alex Martin, former Coherex Medical President and CEO, as Chairman 135
  • 6.31 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer 136
  • 6.32 Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 136
  • 6.33 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 137
  • 6.34 Jun 05, 2017: Baxter Presents Data on Telehealth's Role in Improving Peritoneal Dialysis Patient Care at ERA-EDTA 2017 137
  • 6.35 Jun 02, 2017: New Data from KIHDNEy Cohort Shows Improved Biochemical Outcomes and Broad Range Patient Suitability with More Frequent Hemodialysis Using the NxStage System One 138
  • 6.36 May 30, 2017: Quanta to Exhibit at the 54th ERA-EDTA Congress 139
  • 6.37 May 26, 2017: Merit Medical Announces Appointment of New Director 140
  • 6.38 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 141
  • 6.39 May 18, 2017: Baxter Launches New AK 98 Hemodialysis System Designed To Help Providers Reach Treatment Goals 144
  • 6.40 May 10, 2017: NxStage Medical Announces FDA Clearance for its New System One Hemodialysis System 144
  • 6.41 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 145
  • 6.42 May 09, 2017: Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update 146
  • 6.43 May 09, 2017: Rockwell Medical Reports First Quarter Results 147
  • 6.44 May 09, 2017: NxStage Reports First Quarter Financial Results 147
  • 6.45 May 04, 2017: Teleflex Reports First Quarter 2017 Results 148
  • 6.46 May 03, 2017: Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology 150
  • 6.47 May 03, 2017: Fresenius Medical Care delivers strong first quarter 2017 151
  • 6.48 May 01, 2017: First U.S. Patients Treated with Nikkiso DBB-06 Hemodialysis System at Atlantic Dialysis Management Services 153
  • 6.49 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 153
  • 6.50 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 154
  • 6.51 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 155
  • 6.52 Apr 23, 2017: Bard Announces First Quarter Results 157
  • 6.53 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 158

7 Appendix 232

  • 7.1 Methodology 232
  • 7.2 About GlobalData 235
  • 7.3 Contact Us 235
  • 7.4 Disclaimer 235

List of Tables

1.1 List of Tables

  • Table 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development 15
  • Table 2: Renal Dialysis Equipment - Pipeline Products by Segment 16
  • Table 3: Renal Dialysis Equipment - Pipeline Products by Territory 17
  • Table 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path 18
  • Table 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 19
  • Table 6: Renal Dialysis Equipment - Ongoing Clinical Trials 20
  • Table 7: Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development 21
  • Table 8: Renal Dialysis Equipment - Pipeline Products by Stage of Development 23
  • Table 9: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 10: Resorpor Hemodialysis Graft - Product Status 25
  • Table 11: Resorpor Hemodialysis Graft - Product Description 25
  • Table 12: Advanced Dialysis Methods Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 13: Vibro-Care - Product Status 26
  • Table 14: Vibro-Care - Product Description 26
  • Table 15: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 16: 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Status 27
  • Table 17: 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Description 27
  • Table 18: Vascular Wrap - Product Status 28
  • Table 19: Vascular Wrap - Product Description 28
  • Table 20: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 21: Drug Eluting Tunneled Dialysis Catheter - Product Status 29
  • Table 22: Drug Eluting Tunneled Dialysis Catheter - Product Description 29
  • Table 23: Asahi Kasei Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 24: APS Polysulfone-membrane Artificial Kidney - New Version - Product Status 30
  • Table 25: APS Polysulfone-membrane Artificial Kidney - New Version - Product Description 30
  • Table 26: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 27: MaxFlow - Product Status 31
  • Table 28: MaxFlow - Product Description 31
  • Table 29: SureFlow - Product Status 32
  • Table 30: SureFlow - Product Description 32
  • Table 31: Avenu Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 32: Ellipsys Vascular Access System - Product Status 33
  • Table 33: Ellipsys Vascular Access System - Product Description 33
  • Table 34: AWAK Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 35: AWAK - Product Status 34
  • Table 36: AWAK - Product Description 34
  • Table 37: Baxter BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 38: PRISMAX V2 - Product Status 35
  • Table 39: PRISMAX V2 - Product Description 35
  • Table 40: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 41: AK98 Hemodialysis System - Product Status 36
  • Table 42: AK98 Hemodialysis System - Product Description 37
  • Table 43: Amia Automated PD System With Sharesource - Home Use - Product Status 37
  • Table 44: Amia Automated PD System With Sharesource - Home Use - Product Description 37
  • Table 45: Artis Dialysis System - Product Status 38
  • Table 46: Artis Dialysis System - Product Description 38
  • Table 47: Non PVC CAPD - Product Status 38
  • Table 48: Non PVC CAPD - Product Description 39
  • Table 49: PrisMAX V1 - Product Status 39
  • Table 50: PrisMAX V1 - Product Description 39
  • Table 51: Theralite - Product Status 40
  • Table 52: Theralite - Product Description 40
  • Table 53: VIVIA Hemodialysis System - Product Status 40
  • Table 54: VIVIA Hemodialysis System - Product Description 41
  • Table 55: Baxter International Inc - Ongoing Clinical Trials Overview 42
  • Table 56: VIVIA Hemodialysis System - Sleep Disturbance in Patients with End-stage Renal Disease 43
  • Table 57: VIVIA Hemodialysis System - U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System 43
  • Table 58: Blood Purification Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 59: Wearable Artificial Kidney - Product Status 44
  • Table 60: Wearable Artificial Kidney - Product Description 44
  • Table 61: Brookhaven Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 62: Hemoaccess Valve System - Product Status 45
  • Table 63: Hemoaccess Valve System - Product Description 45
  • Table 64: CatheNect Medical Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 65: Peritoneal Dialysis Catheter - Product Status 46
  • Table 66: Peritoneal Dialysis Catheter - Product Description 46
  • Table 67: Chemica Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 68: Dialysis Regeneration Cartridge - Product Status 47
  • Table 69: Dialysis Regeneration Cartridge - Product Description 47
  • Table 70: Chrysalis Medical Weight Loss Clinic (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 71: Hemodialysis Catheter - Product Status 48
  • Table 72: Hemodialysis Catheter - Product Description 48
  • Table 73: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 74: Lifeline TEBV - AV Shunt - Product Status 49
  • Table 75: Lifeline TEBV - AV Shunt - Product Description 49
  • Table 76: CytoPherx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 77: Selective Cytopheretic Device - Product Status 50
  • Table 78: Selective Cytopheretic Device - Product Description 50
  • Table 79: CytoPherx, Inc. - Ongoing Clinical Trials Overview 51
  • Table 80: Selective Cytopheretic Device - A Multi-center, Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients with Acute Kidney Injury (AKI) 52
  • Table 81: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 82: DialEase - Product Status 53
  • Table 83: DialEase - Product Description 54
  • Table 84: Miniaturized Home Hemodialysis Machine - Product Status 54
  • Table 85: Miniaturized Home Hemodialysis Machine - Product Description 55
  • Table 86: Renal Expres - Product Status 55
  • Table 87: Renal Expres - Product Description 55
  • Table 88: Dipylon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 89: Peripheral Microdialysis Pump Kit - Product Status 56
  • Table 90: Peripheral Microdialysis Pump Kit - Product Description 56
  • Table 91: ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 92: Seraph 200 - Product Status 57
  • Table 93: Seraph 200 - Product Description 57
  • Table 94: Fistulink Ltd. Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 95: Fistulink Device - Product Status 58
  • Table 96: Fistulink Device - Product Description 58
  • Table 97: Flow Forward Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 98: AFE System - Product Status 59
  • Table 99: AFE System - Product Description 59
  • Table 100: Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 101: Portable Artificial Kidney - Product Status 60
  • Table 102: Portable Artificial Kidney - Product Description 60
  • Table 103: Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 104: Mobile Home Hemodialysis device - Product Status 61
  • Table 105: Mobile Home Hemodialysis device - Product Description 62
  • Table 106: Wearable Artificial Kidney - Product Status 62
  • Table 107: Wearable Artificial Kidney - Product Description 62
  • Table 108: XCR-6 - Product Status 63
  • Table 109: XCR-6 - Product Description 63
  • Table 110: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 111: KIDS CRRT - Product Status 64
  • Table 112: KIDS CRRT - Product Description 64
  • Table 113: Pediatric Renal Dialysis Machine - Product Status 65
  • Table 114: Pediatric Renal Dialysis Machine - Product Description 65
  • Table 115: Glomeria Therapeutics srl Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 116: DesmoHD - Product Status 66
  • Table 117: DesmoHD - Product Description 66
  • Table 118: Smart Hemo - Product Status 67
  • Table 119: Smart Hemo - Product Description 67
  • Table 120: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 121: STARcuff - Product Status 68
  • Table 122: STARcuff - Product Description 68
  • Table 123: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 124: Dialysis Cuff - Product Status 69
  • Table 125: Dialysis Cuff - Product Description 69
  • Table 126: Laminate Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 127: VasQ - Product Status 70
  • Table 128: VasQ - Product Description 70
  • Table 129: Laminate Medical Technologies Ltd. - Ongoing Clinical Trials Overview 71
  • Table 130: VasQ - A Multi-center Prospective Study to Evaluate the Safety and Effectiveness of the VasQ External Support for Arteriovenous Fistula 72
  • Table 131: VasQ - A Post Market Surveillance Multi-center Prospective Study to Evaluate the Safety and Efficacy of the VasQ External Support for Arteriovenous Fistula 72
  • Table 132: VasQ - A Prospective, Multi Center, Study to Evaluate the Safety and Efficacy of the VasQ External Support Device for Brachiocephalic Arteriovenous Fistula 72
  • Table 133: LiberDi Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 134: Portable Device - Peritoneal Dialysis - Product Status 73
  • Table 135: Portable Device - Peritoneal Dialysis - Product Description 73
  • Table 136: Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 137: NexSite Hemodialysis Catheter - Product Status 74
  • Table 138: NexSite Hemodialysis Catheter - Product Description 74
  • Table 139: Marvao Medical Devices Ltd - Ongoing Clinical Trials Overview 75
  • Table 140: NexSite Hemodialysis Catheter - Analysis of CRBSI (Catheter-related Blood Stream Infection) Rates in Patients with a NexSite HD (Hemodialysis) Catheter 76
  • Table 141: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 142: Portable Hemodialysis System - Product Status 77
  • Table 143: Portable Hemodialysis System - Product Description 77
  • Table 144: Nanodialysis BV Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 145: NEPHRON+ Wearable Artificial Kidney Device - Product Status 78
  • Table 146: NEPHRON+ Wearable Artificial Kidney Device - Product Description 78
  • Table 147: NanoVasc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 148: NanoVasc Polyurethane Graft - Product Status 79
  • Table 149: NanoVasc Polyurethane Graft - Product Description 79
  • Table 150: Nicast Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 151: Improved Version Of The AVflo Vascular Access Graft - Product Status 80
  • Table 152: Improved Version Of The AVflo Vascular Access Graft - Product Description 80
  • Table 153: Nikkiso Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 154: Blood Volume Monitor For DCG-03 / DBG-03 - Product Status 81
  • Table 155: Blood Volume Monitor For DCG-03 / DBG-03 - Product Description 81
  • Table 156: Next Generation Dialysis Machine - Product Status 82
  • Table 157: Next Generation Dialysis Machine - Product Description 82
  • Table 158: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 159: NuSpun Central Venous Catheter Cuff - Product Status 83
  • Table 160: NuSpun Central Venous Catheter Cuff - Product Description 83
  • Table 161: NuSpun Hemodialysis Access Graft - Product Status 84
  • Table 162: NuSpun Hemodialysis Access Graft - Product Description 84
  • Table 163: NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 164: Next Generation Critical Care System - Product Status 85
  • Table 165: Next Generation Critical Care System - Product Description 85
  • Table 166: NxStage System One - Peritoneal Dialysis - Product Status 86
  • Table 167: NxStage System One - Peritoneal Dialysis - Product Description 86
  • Table 168: Peripal AG Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 169: Chronic Dialysis Patient Aid - Product Status 87
  • Table 170: Chronic Dialysis Patient Aid - Product Description 87
  • Table 171: Phase One Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 172: Goldilocks Valved Hemodialysis Catheter - Product Status 88
  • Table 173: Goldilocks Valved Hemodialysis Catheter - Product Description 88
  • Table 174: Reversus Hemodialysis Catheter - Product Status 89
  • Table 175: Reversus Hemodialysis Catheter - Product Description 89
  • Table 176: qSTAR Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 177: STARport HD - Product Status 90
  • Table 178: STARport HD - Product Description 90
  • Table 179: Quanta Dialysis Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 180: Advanced Haemodialysis System - Nocturnal Use - Product Status 91
  • Table 181: Advanced Haemodialysis System - Nocturnal Use - Product Description 91
  • Table 182: Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 92
  • Table 183: Peritoneal Dialysis Device - Product Status 92
  • Table 184: Peritoneal Dialysis Device - Product Description 92
  • Table 185: Senexis Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93
  • Table 186: Device - Dialysis Related Amyloidosis - Product Status 93
  • Table 187: Device - Dialysis Related Amyloidosis - Product Description 93
  • Table 188: Simergent LLC Pipeline Products & Ongoing Clinical Trials Overview 94
  • Table 189: Automated Peritoneal Dialysis Device - Product Status 94
  • Table 190: Automated Peritoneal Dialysis Device - Product Description 94
  • Table 191: Disposable Tubing Set - Product Status 95
  • Table 192: Disposable Tubing Set - Product Description 95
  • Table 193: Tengion Inc Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 194: Neo-Vessel Replacement - Vascular Access Graft - Product Status 96
  • Table 195: Neo-Vessel Replacement - Vascular Access Graft - Product Description 96
  • Table 196: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 197: Implantable Renal Assist Device - Product Status 97
  • Table 198: Implantable Renal Assist Device - Product Description 97
  • Table 199: Portable Dialysis Machine - Product Status 98
  • Table 200: Portable Dialysis Machine - Product Description 98
  • Table 201: University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 202: Wearable Artificial Kidney - Product Status 99
  • Table 203: Wearable Artificial Kidney - Product Description 99
  • Table 204: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 100
  • Table 205: Bioartificial Kidney - Product Status 100
  • Table 206: Bioartificial Kidney - Product Description 100
  • Table 207: Vital Access Corp Pipeline Products & Ongoing Clinical Trials Overview 101
  • Table 208: Venous Window Access Device - Product Status 101
  • Table 209: Venous Window Access Device - Product Description 101
  • Table 210: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
  • Table 211: Artificial Kidney - Product Status 102
  • Table 212: Artificial Kidney - Product Description 102
  • Table 213: Vizio Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 103
  • Table 214: Ambulatory Wearable Device - Product Status 103
  • Table 215: Ambulatory Wearable Device - Product Description 103
  • Table 216: Glossary 234

List of Figures

1.2 List of Figures

  • Figure 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development 15
  • Figure 2: Renal Dialysis Equipment - Pipeline Products by Segment 16
  • Figure 3: Renal Dialysis Equipment - Pipeline Products by Territory 17
  • Figure 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path 18
  • Figure 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 19
  • Figure 6: Renal Dialysis Equipment - Ongoing Clinical Trials 20
Back to Top